Disc Medicine (IRON) Preferred Shares (2021)
Disc Medicine (IRON) posted quarterly Preferred Shares of $141.9 million for Q4 2021.
Powered by 
Analysis
Disc Medicine (IRON) Preferred Shares (2021) Analysis & Trends
Disc Medicine (IRON) has reported Preferred Shares for 1 consecutive years, with $141.9 million the latest figure, recorded in Q4 2021.
- In Q4 2021, Preferred Shares changed N/A year-over-year to $141.9 million; the TTM figure through Dec 2021 stood at $141.9 million (changed N/A YoY), while the FY2021 annual figure was $141.9 million, changed N/A from the prior year.
- Preferred Shares steadied at $141.9 million in Q4 2021 per IRON's latest filing.
- Across five years, Preferred Shares topped out at $141.9 million in Q4 2021 and bottomed at $141.9 million in Q4 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | - |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | - |
| 10 | Disc Medicine | 3.08 Bn | 3.08 Bn | - | - |